Gujarat Inject FY26 Net Profit Rises 78% to ₹181.41 Lakh

1 min read     Updated on 20 May 2026, 10:27 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Gujarat Inject reported audited standalone financial results for the year ended March 31, 2026, recording a net profit of ₹181.41 lakh, a 78% increase from the previous year. Revenue from operations surged to ₹3,632.04 lakh, while total expenses rose to ₹3,401.26 lakh. For the quarter ended March 31, 2026, net profit stood at ₹163.51 lakh on revenue of ₹3,069.77 lakh.

powered bylight_fuzz_icon
40841275

*this image is generated using AI for illustrative purposes only.

gujarat inject has reported its audited standalone financial results for the year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 20, 2026. The statutory auditors, M/s. S. Mandawat & Co., issued an audit report with an unmodified opinion on the financial statements.

For the fiscal year 2026, the company recorded a net profit of ₹181.41 lakh, a significant increase from ₹101.72 lakh in the previous year. Revenue from operations surged to ₹3,632.04 lakh, up from ₹1,904.58 lakh in FY25. Total income for the year stood at ₹3,651.67 lakh compared to ₹1,922.62 lakh in the corresponding prior period.

Financial Performance Overview

The company's expenses for the year totaled ₹3,401.26 lakh, up from ₹1,797.21 lakh in the previous year. Profit before exceptional items and tax for the year was ₹250.41 lakh, compared to ₹125.41 lakh in FY25. The tax expense for the year amounted to ₹69.00 lakh.

Metric Year Ended 31-03-2026 (₹ in Lakh) Year Ended 31-03-2025 (₹ in Lakh)
Revenue from Operations 3,632.04 1,904.58
Total Income 3,651.67 1,922.62
Total Expenses 3,401.26 1,797.21
Net Profit 181.41 101.72
Basic EPS 1.24 0.70

Quarterly Results

For the quarter ended March 31, 2026, the company reported a net profit of ₹163.51 lakh. Revenue from operations for the quarter stood at ₹3,069.77 lakh. Total income for the quarter was ₹3,069.77 lakh, with total expenses amounting to ₹2,843.26 lakh.

Balance Sheet Highlights

As of March 31, 2026, the company's total assets stood at ₹3,666.52 lakh, a substantial increase from ₹1,195.05 lakh in the previous year. Equity share capital remained constant at ₹1,463.48 lakh. Total current liabilities increased to ₹2,483.54 lakh from ₹193.81 lakh in the prior year.

Given that total current liabilities surged nearly 13x to ₹2,483.54 lakh while equity capital remained unchanged, how will Gujarat Inject manage its liquidity risk and debt obligations in FY27?

With revenue nearly doubling in FY26, what specific sectors or client segments are driving this growth, and is this trajectory sustainable over the next 2-3 years?

Despite revenue doubling, net profit margin remained relatively thin at ~5% — what operational efficiency measures is the company planning to improve profitability in FY27?

Gujarat Inject Kerala Limited Announces Resignation of Managing Director and Appointment of New Whole Time Director

2 min read     Updated on 16 May 2026, 07:24 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Gujarat Inject Kerala Limited's Board of Directors, at its meeting on May 16, 2026, approved the resignation of Mr. Murli Shivshankaran Nair as Managing Director and Chairman with immediate effect, citing personal commitments. Concurrently, Mr. Deepak Diwan Bachwani was appointed as Whole Time Director and designated Chairman, effective May 16, 2026, subject to member approval. Mr. Bachwani is an entrepreneur and strategist with 16+ years of experience in cross-border trade, logistics, and ESG-driven sustainability initiatives across the GCC, Europe, and India. The disclosures were made in compliance with Regulation 30 of the SEBI Listing Regulations, 2015.

powered bylight_fuzz_icon
40485276

*this image is generated using AI for illustrative purposes only.

In a regulatory filing submitted to BSE Limited on May 16, 2026, Gujarat Inject Kerala Limited disclosed key changes to its senior leadership, as approved by its Board of Directors at a meeting held on Saturday, May 16, 2026. The board meeting commenced at 06:00 P.M. and concluded at 06:45 P.M., during which the resignation of the Managing Director and the appointment of a new Whole Time Director were formally taken on record.

Leadership Transition at a Glance

The board approved two significant changes to the company's top management structure on the same date. The following table summarises the key details of both developments:

Parameter: Mr. Murli Shivshankaran Nair Mr. Deepak Diwan Bachwani
Nature of Change: Resignation Appointment
Previous Designation: Managing Director & Chairman Non-Executive Director
New Designation: Whole Time Director & Chairman
Effective Date: May 16, 2026 May 16, 2026
DIN: 02243039 05302407

Resignation of Managing Director

Mr. Murli Shivshankaran Nair tendered his resignation from the office of Managing Director (Director and KMP) and Chairman of the company vide resignation letter dated May 16, 2026, citing pre-occupation and other personal commitments. He was relieved from his responsibilities with immediate effect. Mr. Nair confirmed that there are no other material reasons for his resignation beyond those stated in his resignation letter. The resignation was accepted by the Board and the necessary regulatory disclosures have been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment of New Whole Time Director

Following Mr. Nair's departure, the Board approved the appointment of Mr. Deepak Diwan Bachwani as Whole Time Director, marking a change in his designation from Non-Executive Director to Whole Time Director. He has also been designated as Chairman of the company, effective May 16, 2026. This appointment is subject to the approval of members at the ensuing general meeting.

Profile of the Incoming Director

Mr. Deepak Diwan Bachwani brings a diverse professional background to his new executive role. Key highlights of his profile include:

  • Experience: Entrepreneur and strategist with 16+ years of experience
  • Core Areas: Cross-border trade, logistics, and ESG-driven sustainability and carbon credit initiatives
  • Expertise: Building high-trust international supply chains and creating circular-economy solutions
  • Geographic Reach: Scaling green ventures across the GCC, Europe, and India
  • Approach: Combining commercial acumen with a purpose-driven approach to deliver business impact and societal value

Regulatory Compliance

The disclosures were made pursuant to Regulation 30 read with Part A, Para A of Schedule III of the SEBI Listing Regulations, 2015, and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. All requisite details, including the resignation letter, have been enclosed with the filing submitted to the Listing Department of BSE Limited.

How might Mr. Bachwani's expertise in cross-border trade and carbon credit initiatives shift Gujarat Inject Kerala Limited's strategic focus and revenue mix over the next 12-24 months?

Will the simultaneous resignation of the founding Managing Director and the transition to a new Chairman create any short-term operational or investor confidence challenges for the company?

Could Mr. Bachwani's background in GCC and European green ventures signal a potential pivot toward ESG-linked business segments or international market expansion for the company?

More News on Gujarat Inject